http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20070072-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-46
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ccdc7c94c8b98500db76259d6460bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea2b5dff28b6345c5d442a796d30265b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1d520e6e4ecd495ee8a5e1e4cdefaa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92779298daa29dad5dcb296b72828742
publicationDate 2007-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20070072-A1
titleOfInvention MANUFACTURING PROCESS FOR TIGECYCLINE AS RECONSTITUTABLE POWDER
abstract REFERRING TO A PROCESS FOR THE ELABORATION OF TIGECYCLINE AS A RECONSTITUTABLE POWDER THAT HAS LESS THAN 0.9% TOTAL DEGRADANTS, WHERE SUCH PROCESS INCLUDES: a) REDUCE AND MAINTAIN THE LEVEL OF OXYGEN IN WATER FOR LESS INJECTION (W OR LESS) AT 0.5 ppm, KEEPING THE TEMPERATURE BETWEEN 2ºC AND 8ºC, b) FORM A TIGECYCLINE SOLUTION IN SAID WATER FROM THE PREVIOUS PASSAGE AT A CONCENTRATION OF BETWEEN 10 TO 50 MG / ML, KEEPING THE TEMPERATURE AND OXYGEN LEVEL, c) FILLING THE BOTTLES WITH THE FORMED SOLUTION, d) FREEZE THE STEP C SOLUTION FORMING 25 MG TO 150 MG OF RECONSTITUTABLE POWDER IN A BOTTLE AND e) SEAL THE BOTTLE UNDER NITROGEN. SAID PREPARATION OF TIGECYCLINE IS FOR INJECTIONS
priorityDate 2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686904

Total number of triples: 34.